ArticlePLoS biology2026
A dual-threshold system relying on multiple c-di-GMP metabolic enzymes controls cell fate of a cyanobacterium.
Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cyclic-di-GMP (c-di-GMP) is a ubiquitous second messenger in bacteria and regulates a variety of cell activities. Many bacteria contain multiple enzymes involved in c-di-GMP synthesis or degradation; however, how they coordinate with each other to orchestrate c-di-GMP homeostasis remains unclear. Here, using the cyanobacterium Anabaena PCC 7120 as a model, we created cdG0 and cdGmax strains by deleting all 8 and 14 genes, respectively, that encode enzymes with c-di-GMP degradation and synthesis domains, alongside a collection of mutants with various numbers of these genes deleted. Our findings demonstrate that c-di-GMP in Anabaena not only modulates cell size but is also indispensable for cell viability. Quantitative analysis established two critical physiological thresholds in vivo: a minimal c-di-GMP level required for cell size maintenance and a lower, lethal threshold essential for survival. We show that the 16 enzymes involved in c-di-GMP turnover in Anabaena function as an electromechanical-like dual relay to control c-di-GMP dynamics, with different modules contributing to c-di-GMP homeostasis or responding as an SOS alarm when the c-di-GMP concentration drops below the lethal threshold. Both effects of c-di-GMP on cell size reduction and cell viability are mediated by the cyclic-di-GMP receptor (CdgR), depending on the amount of the c-di-GMP-free form of CdgR available because of titration by c-di-GMP in the cells. The system, with the two concentration thresholds of c-di-GMP that dictate cell size and viability, respectively, enables dynamic cellular adaptation while preventing lethal effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.